Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease.
Amy Y LiShaina SedighimFatemeh TajikAaqil M KhanVinodh K RadhakrishnanFarshid DayyaniMaheswari SenthilPublished in: Journal of gastrointestinal cancer (2024)
IP chemotherapy has a clear role in the management of patients with GCPC, and when combined with CRS in appropriately selected patients has the potential to significantly improve survival. Ongoing and upcoming IP therapy clinical trials hold great promise to shape the treatment paradigm for GCPC.
Keyphrases
- clinical trial
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- squamous cell carcinoma
- patient reported outcomes
- big data
- machine learning
- mesenchymal stem cells
- locally advanced
- smoking cessation
- artificial intelligence
- deep learning
- open label